Industry News
The first far ultraviolet spectra of a cometary surface
NASA's Alice ultraviolet (UV) spectrograph, located aboard the European Space Agency's Rosetta comet orbiter, has made the first far ultraviolet spectra of a cometary surface. [ + ]
Antisense's ATL1103 shows promise in acromegaly
Antisense Therapeutics' (ASX:ANP) ATL1103 candidate reduced sIGF-I levels in patients with the growth disorder acromegaly during a phase II trial.
[ + ]Federal court upholds decision on Myriad patent
The Federal Court of Australia has upheld its decision from last year in favour of Myriad Genetics patenting isolated DNA associated with breast cancer gene mutations. [ + ]
Support for Chief Scientist's STEM report
Australia's Chief Scientist, Professor Ian Chubb, has released his recommendations for a strategic approach to science and its related fields. [ + ]
Plants help create happy office vibes
Putting plants in the office makes for happier staff and boosts productivity. [ + ]
Action urged to capitalise on opportunity as Budget tables reveal loss of support
The release of the federal government's Science, Research and Innovation Budget Tables this week reveals the losses of almost $400m to science, research and innovation, prompting AusBiotech to reinforce its calls for urgent and specific action that will drive growth in the biotechnology industry and, therefore, the Australian economy.
[ + ]Australia needs a science strategy
Chief Scientist Ian Chubb has called for a coherent, strategic and long-term approach to science in Australia. [ + ]
GSK to shut down Medicines Research Unit
GSK will cease operation of its research unit at Sydney's Prince of Wales Hospital at the end of the month, laying off eight employees and five contractors. [ + ]
Remote lab program receives international award
A futuristic science education program, which lets high-school students take control of live experiments from anywhere in the country, has received a prestigious award from the UK's Institute of Science and Technology. [ + ]
Pharmaxis to take anti-inflammatory to human trials
Pharmaxis (ASX:PXS) plans to conduct the first human trials of PXS4728A - a drug candidate for inflammatory diseases including COPD and NASH - in 1Q15.
[ + ]More funding for medical research
New treatments, improved research translation and Indigenous youth suicide are some of the areas to benefit from the latest NHMRC grant announcement. [ + ]
TGA joins international collaboration to evaluate generic drugs
The Therapeutic Good Administration (TGA) has joined a pilot of the Decentralised Procedure (DCP) of the European Union - a collaboration on the evaluation of generic drug applications. [ + ]
Infrastructure contract for new CCS activities
CO2CRC and The University of Melbourne have announced an $18 million infrastructure contract to purchase new laboratories, plant and equipment to be used in a range of carbon capture and storage (CCS) activities over the next five years. [ + ]
Minomic forges prostate cancer partnership
Minomic International and US-based Catalent Pharma Solutions will jointly develop the former's MIL-38 antibody drug conjugate into a potential new treatment for prostate cancer.
[ + ]Finalists for Qualcomm Tricorder XPRIZE announced
The finalists for the Qualcomm Tricorder XPRIZE have been announced. The $10 million global competition asks teams to develop a consumer-focused, mobile device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics. [ + ]
